Icon

AmpliPhi Biosciences Corporation Stock Analysis and Price Target COMMON STOCK | Other | NYE

stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.12

0.00 (0.00)%

USD 0.15B

1.67M

N/A

N/A

Icon

APHB

AmpliPhi Biosciences Corporation (USD)
COMMON STOCK | NYE
USD 0.12
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.15B

N/A

USD 0.12

AmpliPhi Biosciences Corporation Stock Forecast

N/A

Based on the AmpliPhi Biosciences Corporation stock forecast from 0 analysts, the average analyst target price for AmpliPhi Biosciences Corporation is not available over the next 12 months. AmpliPhi Biosciences Corporation’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of AmpliPhi Biosciences Corporation is Very Bearish, which is based on 0 positive signals and 1 negative signals. At the last closing, AmpliPhi Biosciences Corporation’s stock price was USD 0.12. AmpliPhi Biosciences Corporation’s stock price has changed by +0.00% over the past week, +0.00% over the past month and +0.00% over the last year.

No recent analyst target price found for AmpliPhi Biosciences Corporation
No recent average analyst rating found for AmpliPhi Biosciences Corporation

Company Overview

As of May 9, 2019, was acquired by C3J Therapeutics, Inc., in a reverse merger transaction.

http://www.ampliphibio.com

3579 Valley Centre Drive, Suite 100 92130,San Diego,USA

30

December

USD

USA

Adjusted Closing Price

Loading...

Technical Indicators

Unadjusted Closing Price

Loading...

Assets

Top Holdings

Top Sectors

Top Regions

Share Volume

Loading...

Relative Performance

Symbol Capital Gain Dividend Return Total Return
Loading...

Stocks Similar To AmpliPhi Biosciences Corporation (Sector: Other )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
BMS
Bemis Company, Inc 0.00 (0.00%) USD370,676,430.93B 1,000,000.00 N/A

ETFs Containing APHB

Symbol Name APHB's Weight Expense Ratio Price(Change) Market Cap
MVS:AU
VanEck Vectors Small Comp.. 2.72 % 0.49 % -0.15 (-0.83%) USD0.05B

Frequently Asked Questions About APHB Stock

Stock Target Advisor's fundamental analysis for AmpliPhi Biosciences Corporation's stock is Very Bearish.

Unfortunately we do not have enough data on APHB's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on APHB's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on APHB's stock to indicate if its overvalued.

The last closing price of APHB's stock was USD 0.12.

The most recent market capitalization for APHB is USD 0.15B.

Unfortunately we do not have enough analyst data on APHB's stock to indicate whether its price will go up or not.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...